109055007: Octreotide acetate (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\...

\Peptide hormone\Somatostatin analog (substance)\Octreotide acetate

\Hypothalamic inhibiting factor\Somatostatin analog (substance)\Octreotide acetate

\Gastrointestinal hormone\Somatostatin analog (substance)\Octreotide acetate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\...

\Peptide hormone\Somatostatin analog (substance)\Octreotide acetate

\Cyclic peptide (substance)\Octreotide acetate

\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Cyclic peptide (substance)\Octreotide acetate
\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Peptide hormone\Somatostatin analog (substance)\Octreotide acetate
\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Cyclic peptide (substance)\Octreotide acetate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

173590013 Octreotide acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

607692011 Octreotide acetate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

13291000188117 octréotide acétate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

829071000172118 acétate d'octréotide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Octreotide acetate	Is a	Octreotide	false	Inferred relationship	Some
Octreotide acetate	Is a	Acetate	false	Inferred relationship	Some
Octreotide acetate	Is a	Product containing octreotide (medicinal product)	false	Inferred relationship	Some
Octreotide acetate	Is a	Acetate compound	false	Inferred relationship	Some
Octreotide acetate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Hypothalamic inhibiting factor (disposition)	true	Inferred relationship	Some
Octreotide acetate	Is a	Cyclic peptide (substance)	true	Inferred relationship	Some
Octreotide acetate	Is a	Somatostatin analog (substance)	true	Inferred relationship	Some
Octreotide acetate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Octreotide	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Octreotide acetate preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Octreotide acetate 100mcg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Octreotide acetate 500mcg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Octreotide acetate 200mcg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Octreotide acetate 10mg depot injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Octreotide acetate 20mg depot injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Octreotide acetate 30mg depot injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Octreotide acetate 50mcg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Octreotide acetate 1mg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Octreotide 500micrograms/mL injection solution 1mL ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Octreotide 1mg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Octreotide 200micrograms/mL injection solution 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Octreotide 100micrograms/mL injection solution 1mL ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Octreotide 50micrograms/mL injection solution 1mL ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Octreotide acetate	Inferred relationship	Some
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Octreotide acetate	Inferred relationship	Some	1
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Octreotide acetate	Inferred relationship	Some	1
Octreotide (as octreotide acetate) 30 mg powder for suspension for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Octreotide acetate	Inferred relationship	Some	1
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Octreotide acetate	Inferred relationship	Some	1
Product containing precisely octreotide (as octreotide acetate) 1 milligram/5 milliliter conventional release solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Octreotide acetate	Inferred relationship	Some	1
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Octreotide acetate	Inferred relationship	Some	1
Product containing precisely octreotide (as octreotide acetate) 50 microgram/1 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Octreotide acetate	Inferred relationship	Some	1
Product containing precisely octreotide (as octreotide acetate) 200 microgram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Octreotide acetate	Inferred relationship	Some	1
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Octreotide acetate	Inferred relationship	Some	1
Octreotide (as octreotide acetate) 50 microgram/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Octreotide acetate	Inferred relationship	Some	1
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Octreotide acetate	Inferred relationship	Some	1

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
173590013	Octreotide acetate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
607692011	Octreotide acetate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
13291000188117	octréotide acétate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
829071000172118	acétate d'octréotide	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module